Latest Breaking News On - Pecializing alonx fr0010095596 - Page 1 : comparemela.com

All the resolutions approved by the Board of Directors were adopted Paris , June 6, 2023 - 6:30 pm CEST - Onxeo S.A. , a clinical-stage biotechnology company specializing in. | June 6, 2023

France generalRobert colemanNicolas treboutaOnxeo sa euronextEuronext growth parisAnnual general meetingValerio therapeuticOnxeo stock exchangePress releasePecializing alonx fr0010095596